These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

257 related articles for article (PubMed ID: 21459738)

  • 21. An independent AGREE evaluation of the Occupational Medicine Practice Guidelines.
    Cates JR; Young DN; Bowerman DS; Porter RC
    Spine J; 2006; 6(1):72-7. PubMed ID: 16413451
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Recommendations from treatment guidelines for schizophrenia regarding monitoring of side effects of antipsychotics: brief review.
    Kozumplik O; Uzun S
    Psychiatr Danub; 2009 Mar; 21(1):95-8. PubMed ID: 19270630
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Algorithm for treatment-refractory schizophrenia.
    Koshino Y
    Psychiatry Clin Neurosci; 1999 Oct; 53 Suppl():S9-13. PubMed ID: 10560891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ministry of Health clinical practice guidelines: schizophrenia.
    Verma S; Chan LL; Chee KS; Chen H; Chin SA; Chong SA; Chua W; Fones C; Fung D; Khoo CL; Kwek SK; Ling J; Poh P; Sim K; Tan BL; Tan C; Tan CH; Tan LL; Tay WK;
    Singapore Med J; 2011 Jul; 52(7):521-5; quiz 526. PubMed ID: 21808964
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Treatment of unipolar psychotic depression: the use of evidence in practice guidelines.
    Wijkstra J; Schubart CD; Nolen WA
    World J Biol Psychiatry; 2009; 10(4 Pt 2):409-15. PubMed ID: 17963187
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Relapse prevention and recovery in the treatment of schizophrenia.
    Schooler NR
    J Clin Psychiatry; 2006; 67 Suppl 5():19-23. PubMed ID: 16822093
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Review: Combination therapy with non-clozapine atypical antipsychotic medication: a review of current evidence.
    Chan J; Sweeting M
    J Psychopharmacol; 2007 Aug; 21(6):657-64. PubMed ID: 17092976
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The NIMH-CATIE Schizophrenia Study: what did we learn?
    Lieberman JA; Stroup TS
    Am J Psychiatry; 2011 Aug; 168(8):770-5. PubMed ID: 21813492
    [No Abstract]   [Full Text] [Related]  

  • 29. Lessons from STEP-BD for the treatment of bipolar depression.
    Nierenberg AA
    Depress Anxiety; 2009; 26(2):106-9. PubMed ID: 19177467
    [No Abstract]   [Full Text] [Related]  

  • 30. Psychopharmacology of schizophrenia in children and adolescents.
    Carlisle LL; McClellan J
    Pediatr Clin North Am; 2011 Feb; 58(1):205-18, xii. PubMed ID: 21281857
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The management of difficult to treat patients with schizophrenia, using non-drug therapies.
    Kuipers E
    Br J Psychiatry Suppl; 1996 Dec; (31):41-51. PubMed ID: 8968654
    [No Abstract]   [Full Text] [Related]  

  • 32. Outcome in schizophrenia: beyond symptom reduction.
    Meltzer HY
    J Clin Psychiatry; 1999; 60 Suppl 3():3-7; discussion 8. PubMed ID: 10073370
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Clozapine for treatment-resistant schizophrenia: National Institute of Clinical Excellence (NICE) guidance in the real world.
    Mortimer AM; Singh P; Shepherd CJ; Puthiryackal J
    Clin Schizophr Relat Psychoses; 2010 Apr; 4(1):49-55. PubMed ID: 20643629
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Promoting evidence-based practice in spinal cord injury/disorders health care.
    Nelson A; Weaver FM
    SCI Nurs; 2004; 21(3):129-35. PubMed ID: 15553055
    [No Abstract]   [Full Text] [Related]  

  • 35. Antipsychotic medication use patterns and associated costs of care for individuals with schizophrenia.
    Loosbrock DL; Zhao Z; Johnstone BM; Morris LS
    J Ment Health Policy Econ; 2003 Jun; 6(2):67-75. PubMed ID: 14578539
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Schizophrenia treatment: content versus delivery.
    van Os J
    Acta Psychiatr Scand Suppl; 2009; (438):29-32. PubMed ID: 19132964
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Better prognosis due to new treatment approaches. Therapy of schizophrenia in 2002].
    Janssen B; Gaebel W
    MMW Fortschr Med; 2002 May; Suppl 2():72-6, 78. PubMed ID: 12070858
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Expert opinion on APAP (prolonged action atypical antipsychotic agents). What are the limiting factors in resort to an APAP and how to overcome them].
    Canceil O; Limosin F; Passerieux C
    Encephale; 2009 Jan; Suppl 3():S101-7. PubMed ID: 19268178
    [No Abstract]   [Full Text] [Related]  

  • 39. Depot neuroleptics: the relevance of psychosocial factors--a United States perspective.
    Hogarty GE
    J Clin Psychiatry; 1984 May; 45(5 Pt 2):36-42. PubMed ID: 6143746
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A successful effort to improve adherence to treatment guidelines for bipolar disorder.
    Smith TE; Levine SB; Hampel J
    Harv Rev Psychiatry; 2008; 16(3):210-3. PubMed ID: 18569042
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.